Literature DB >> 22089187

Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia.

Patrik Andersson1, Olof Gidlöf, Oscar O Braun, Matthias Götberg, Jesper van der Pals, Björn Olde, David Erlinge.   

Abstract

Tissue-specific circulating micro-RNAs (miRNAs) are released into the blood after organ injury. In an ischemic porcine cardiogenic shock model, we investigated the release pattern of cardiac-specific miR-208b and liver-specific miR-122 and assessed the effect of therapeutic hypothermia on their respective plasma levels. Pigs were anesthetized, and cardiogenic shock was induced by inflation of a percutaneous coronary intervention balloon in the proximal left anterior descending artery for 40 min followed by reperfusion. After fulfillment of the predefined shock criteria, the pigs were randomized to hypothermia (33°C, n = 6) or normothermia (38°C, n = 6). Circulating miRNAs were extracted from plasma and measured with quantitative real-time polymerase chain reaction (PCR). Tissue specificity was assessed by miRNA extraction from porcine tissues followed by quantitative real-time PCR. In vitro, the release of miR-122 from a cultured hepatocyte cell line exposed to either hypoxia or acidosis was assessed by real-time PCR. miR-122 was found to be highly liver specific, whereas miR-208b was expressed exclusively in the heart. In the control group, ischemic cardiogenic shock induced a 460,000-fold and a 63,000-fold increase in plasma levels of miR-122 (P < 0.05) and miR-208b (P < 0.05), respectively. Therapeutic hypothermia significantly diminished the increase in miR-122 compared with the normothermic group (P < 0.005). In our model, hypothermia was initiated after coronary reperfusion and did not affect either myocardial damage as previously assessed by magnetic resonance imaging or the plasma level of miR-208b. Our results indicate that liver-specific miR-122 is released into the circulation in the setting of cardiogenic shock and that therapeutic hypothermia significantly reduces the levels of miR-122.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22089187     DOI: 10.1097/SHK.0b013e31823f1811

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  27 in total

1.  Comprehensive analysis of human small RNA sequencing data provides insights into expression profiles and miRNA editing.

Authors:  Jing Gong; Yuliang Wu; Xiantong Zhang; Yifang Liao; Vusumuzi Leroy Sibanda; Wei Liu; An-Yuan Guo
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 2.  The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.

Authors:  Stępień E; Marina C Costa; Szczepan Kurc; Anna Drożdż; Nuno Cortez-Dias; Francisco J Enguita
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

3.  What's new in prognostication after cardiac arrest: microRNAs?

Authors:  Yvan Devaux; Pascal Stammet
Journal:  Intensive Care Med       Date:  2017-11-20       Impact factor: 17.440

4.  MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine.

Authors:  Wei-Bin Lin; Meng-Ya Liang; Guang-Xian Chen; Xiao Yang; Han Qin; Jian-Ping Yao; Kang-Ni Feng; Zhong-Kai Wu
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 5.  MicroRNAs as pharmacological targets in diabetes.

Authors:  Yiping Mao; Ramkumar Mohan; Shungang Zhang; Xiaoqing Tang
Journal:  Pharmacol Res       Date:  2013-06-28       Impact factor: 7.658

Review 6.  Target biomarker profile for the clinical management of paracetamol overdose.

Authors:  A D Bastiaan Vliegenthart; Daniel J Antoine; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2015-07-29       Impact factor: 4.335

Review 7.  Current review of machine perfusion in liver transplantation from the Japanese perspective.

Authors:  Noboru Harada; Tomoharu Yoshizumi; Masaki Mori
Journal:  Surg Today       Date:  2021-03-22       Impact factor: 2.549

8.  Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases.

Authors:  Yong Jiang; Hui-yan Wang; Yan Li; Su-hong Guo; Lei Zhang; Jian-hui Cai; Hong-mei Cao; Chun-yan Wang; Hao Wang; Lei Liu
Journal:  Sci Rep       Date:  2014-05-22       Impact factor: 4.379

9.  Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis.

Authors:  James L Weemhoff; Benjamin L Woolbright; Rosalind E Jenkins; Mitchell R McGill; Matthew R Sharpe; Jody C Olson; Daniel J Antoine; Steven C Curry; Hartmut Jaeschke
Journal:  Liver Int       Date:  2016-08-06       Impact factor: 5.828

10.  Use of miRNAs in biofluids as biomarkers in dietary and lifestyle intervention studies.

Authors:  Sophie Rome
Journal:  Genes Nutr       Date:  2015-08-02       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.